Getting it together: Signal transduction in G-protein coupled receptors by association of receptor domains

Chemistry and Biology

Volumn 4, Issue 4, 1997, Pages 239-248

  Underwood, Dennis J ^a   Prendergast, Kristine ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031127688     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90067-3     Document Type: Note

References (81)

1. Hollenberg, M. (1990). Receptor triggering and receptor regulation: structure-activity relationships from the receptors point of view. J. Med. Chem. 33, 1275-1281.
2. Lauffenburger, D. & Linderman, J. (1993). Receptors: Models for Binding, Trafficking and Signaling. Oxford University Press, New York, USA.
3. Stouch, T. (1993). Lipid membrane structure and dynamics studied by all-atom molecular dynamics simulations of hydrated phospholipid bilayers. Mol. Simul. 10, 317-345.
4. Bassolino, D. Alper, H.E. & Stouch, T.R. (1995). Mechanism of solute diffusion though lipid bilayer membranes by molecular dynamics simulation. J. Am. Chem. Soc. 117, 4118-4129.
5. Collings, P. (1990). Liquid Crystals. Princeton University Press, Princeton, USA.
6. Strader, C., Fong, T., Tota, M., Underwood, D. & Dixon, R. (1994). Structure and function of G protein coupled receptors. Annu. Rev. Biochem. 63, 101-132.
7. Hamm, H. & Gilchrist, A. (1996). Heterotrimeric G proteins. Curr. Opin. Cell Biol. 8, 189-196.
8. Reiss, Y., Stradley, S., Gierasch, L., Brown, M. & Goldstein, J. (1991). Sequence requirement for peptide recognition by rat brain p21 ras protein farnesyl transferase. Proc. Natl Acad. Sci. USA 88, 732-736.
9. Moores., S. (1991). Sequence dependence of protein isoprenylation. J. Biol. Chem. 266, 14603-14610.
10. Petracchi, D., Lucia, S. & Cercignani, G. (1994). Photobehavior of Halobacterium-Halobium; proposed models for signal transduction and motor switching. J. Photochem. Photobiol. B: Biol. 24, 75-99.
11. Heldin, C.-H. (1995). Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
12. Malinin, N., Boldin, M., Kovalenko, A. & Wallach, D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
13. De Vos, A., Ultsch, M. & Kossiakoff, A. (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.
14. Wells, J. & De Vos, A. (1996). Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609-634.
15. Stahl, N. & Yancopoulos, G. (1994). The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J. Neurobiol. 25, 1454-1466.
16. Sorokin, A., Lemmon, M. & Schlessinger, J. (1994). Stabilization of an active dimeric form of the epidermal growth-factor receptor by introduction of an inter-receptor disulfide bond. Biochemistry 269, 9752-9759.
17. Banner, D., et al., & Lesslauer, W. (1993). Crystal structure of the soluble human 55KD TNF receptor-human TNF-beta complex: implications for TNF receptor activation. Cell 73, 431-445.
18. Eck, M. & Sprang, S. (1989). Structure of tumor necrosis factor. J. Biol. Chem. 264, 17595-17605.
19. Jones, E., Stuart, D., & Walker, N. (1989). The structure of tumor necrosis factor at 2.6 A resolution. Nature 338, 225-228.
20. Humblet, C. & Mirzadegan, T. (1992). In Annual Reports in Medicinal Chemistry (Bristol, J., ed.), Academic Press Inc., San Diego, USA.
21. Ren, Q., Kurose, H., Lefkowitz, R.J. & Cotecchia, S. (1993). Constitutively active mutants of the alpha-2-adrenergic receptor. J. Biol. Chem. 268, 16483-16487.
22. Samama, P., Cotecchia, S., Costa, T. & Lefkowitz, R.J. (1993). A mutation-induced activated state of the beta(2)-adrenergic receptor - extending the ternary complex model. J. Biol. Chem. 268, 4625-4636.
23. Boone, C., Davis, N.G. & Sprague G.F. (1993). Mutations that alter the 3rd cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype. Proc. Natl Acad. Sci. USA 90, 9921-9925.
24. Lefkowitz, R.J., Cotecchia, S., Samama, P. & Costa, T. (1993). Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-307.
25. Fong, T., Huang, R. & Strader, C. (1992). Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 267, 25664-25667.
26. Kahn, T. & Engelman, D.M. (1992). Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five-helix fragment. Biochemistry 31, 6114-6151.
27. Kahn, T., Sturtevant, J. & Engelman, D. (1992). Thermodynamic measurements of the contributions of helix-connecting loops and of retinal to the stability of Bacteriorhodopsin. Biochemistry 31, 8829-8839.
28. Kobilka, B., Kobilka, T., Daniel, K., Regan, J., Caron, M. & Lefkowitz, R. (1988). Chimeric alpha2 and beta2 adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240, 1310-1360.
29. Maggio, R., Vogel, Z. & Wess, J. (1993). Coexpression studies with mutant muscarinic adrenergic-receptors provide evidence for intermolecular cross-talk between G-protein-linked receptors. Proc. Natl Acad. Sci. USA 90, 3103-3107.
30. Maggio, R., Vogel, Z. & Wess, J. (1993). Reconstitution of functional muscarinic receptors by co-expression of amino and carboxyl terminal receptor fragments. FEBS Lett. 319, 195-200.
31. Wess, J. (1993). Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol. Sci. 14, 308-313.
32. Marie, J., et al., & Bonnafous, J.C. (1994). Tyr(292) in the 7th transmembrane domain of the AT(1 a) Angiotensin-ii receptor is essential for its coupling to Phospholipase-C. J. Biol. Chem. 269, 20815-20818.
33. Hunyady, L., Bor, M., Baukal, A., Balla, T. & Catt, K. (1995). A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type-I Angiotensin-II receptor. J. Biol. Chem. 270, 16602-16609.
34. Horstman, D., Brandon, S., Wilson, A., Guyer, C., Cragoe, E. & Limbird, L.E. (1990). An aspartate conserved among G-protein receptors confers allosteric regulation of a2-adrenergic receptors by sodium. J. Biol. Chem. 265, 21590-21595.
35. Chabre, O., Conklin, B.R., Brandon, S., Bourne, H.R. & Limbird, L.E. (1994). Coupling of the Alpha(2a)-Adrenergic receptor to multiple G-Proteins - a simple approach for estimating receptor-G-Protein coupling efficiency in a transient expression system. J. Biol. Chem. 269, 5730-5734.
36. Fong, T., et al., & Strader, C.D. (1994) Mutational analysis of neurokinin receptor function. Peptide Symp., Montreal, Canada.
37. Zhou, W., et al., & Sealfon, S.C. (1994). A reciprocal mutation supports helix-2 and helix-7 proximity in the gonadatropin-releasing - hormone receptor. J. Mol. Endocrinol. 45, 165-170.
38. Cook, J., Faccenda, E., Anderson, L., Couper, G., Eidne, K. & Taylor, P. (1994). Effects of Asn 87 and Asp 318 mutations on ligand binding and signal transduction in the rat GnRH receptor. J. Mol. Endocrinol. R1-R4.
39. Pittel, Z. & Wess, J. (1994). Intramolecular interactions in muscarinic acetylcholine-receptors studied with chimeric m2/m5 receptors. Mol. Pharmacol. 45, 61-64.
40. Underwood, D., Strader, C., Rivero, R., Patchett, A., Greenlee, W. & Prendergast, K. (1994). Structural model of antagonist and agonist binding to the Angiotensin-II, AT1 subtype G-protein coupled receptor. Chem. Biol. 1, 211-221.
41. Strader, C.D. (1993). Mapping the ligand-binding sites of G-protein coupled receptors. Abstr. Papers Am. Chem. Soc. 206, 262.
42. Strader, C., Candelore, M., Hill, W., Sigal, I. & Dixon, R. (1989). Identification of two serine residues involved in agonist activation of the b adrenergic receptor. J. Biol. Chem. 264, 13572-13578.
43. Dixon, R., et al., & Strader, C.D. (1989). Genetic analysis of the molecular basis for βadrenergic receptor subtype specificity. Proteins 6, 267-274.
44. Tota, M. & Strader, C. (1990). Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site. J. Biol. Chem. 265, 16891-16897.
45. Fong, T.M., Huang, R., Yu, H. & Strader, C.D. (1993). Ligand-receptor interactions at neurokinin receptors. J. Neurochem. 61, 63.
46. Fong, T.M., Huang, R., Yu, H. & Strader, C.D. (1993). Mapping the ligand-binding site of the nk-1 receptor. Regul. Pept. 46, 43-48.
47. Siciliano, S., et al., & Springer, M. (1994). Two-site binding of C5a by its receptor: an alternative binding paradigm for G-protein-coupled receptors. Proc. Natl Acad. Sci. USA 91, 1214-1218.
48. Rao, V., Cohen, G., & Oprian, D. (1994). Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639-642.
49. Nissenson, R.A., Huang, Z.M., Blind, E. & Shoback, D. (1993). Structure and function of the receptor for parathyroid-hormone and parathyroid hormone-related protein. Receptor 3, 193-202.
50. Shinagawa, K., Ohya, M., Higashijima, T. & Wakamatsu, K. (1994). Circular-dichroism studies of the interaction between synthetic peptides corresponding to intracellular loops of beta-adrenergic receptors and phospholipid-vesicles. J. Biochem. 115, 463-468.
51. Bluml, K., Mutschler, E. & Wess, J. (1994). Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 269, 402-405.
52. Tian, W.-N. (1993). Precoupling of Gi/Go-linked receptors and its allosteric regulation by monovalent cations. Life Sci. 52, 1899-1907.
53. Shi, A.-G. & Deth, R. (1994). Precoupling of alpha-2B adrenergic receptors and G-proteins in transfected PC-12 cell membranes - influence of pertussis toxin and a lysine directed cross-linker. J. Pharmacol. Exp. Therapeut. 271, 1520-1527.
54. Kermode, J., DeLuca, A., Zilberman, A., Valliere, J. & Shreeve, S. (1992). Evidence for the formation of a functional complex between vasoactive intestinal peptide, its receptor and Gs in lung membranes. J. Biol. Chem. 267, 3382-3388.
55. 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27, 2374-2384.
56. Li, L-Y., Zhang, Z.-M., Su, Y.-F., Watkins, W. & Chang, K.-J. (1992). Purification of opioid receptor in the presence of sodium ions. Life Sci. 51, 1177-1185.
57. Posner, R., Fay, S., Domalewski, M. & Sklar, I. (1994). Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions. Mol. Pharmacol. 45, 65-73.
58. Chidiac, P. (1995). Receptor state and ligand efficacy. Trends Pharmacol. Sci. 16, 83-84.
59. Kenakin, T. (1995). Pharmacological proteus? Trends Pharmacol. Sci. 16, 256-258.
60. Kenakin, T. (1995). Efficacy as the molecular property of a ligand. Trends Pharmacol. Sci. 16, 84-85.
61. Leff, P. (1995). The two state model of receptor activation. Trends Pharmacol. Sci. 16, 89-97.
62. Milligan, G., Bond, R. & Lee, M. (1995). Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16, 10-13.
63. Costa, T., Ogino, Y., Munson, P., Onarau, H. & Rodbard, D. (1992). Drug efficacy at guanine nucleotide binding regulatory protein linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41, 549-560.
64. Searle, M. & Williams, D. (1992). The cost of conformational order: entropy changes in molecular associations. J. Am. Chem. Soc. 114, 10690-10697.
65. Weiland, G., Minneman, K. & Molinoff, P. (1979). Fundamental differences between the molecular interactions of agonists and antagonists with the β-adrenergic receptor. Nature 281, 114-117.
66. Miclavc, A., Kocjan, D., Mavri, J., Koller, J. & Hadzi, D. (1990). On the fundamental difference in the thermodynamics of agonist and antagonist interactions with β-adrenergic receptors and the mechanism of entropy driven binding. Biochem. Pharmacol. 40, 663-669.
67. Gilli, R, Ferretti, V., Gilli, G. & Borea, P.A. (1994). Enthalpy-entropy compensation in drug-receptor binding. J. Phys. Chem. 98, 1515-1518.
68. Contreras, M., Wolfe, B. & Molinoff, P. (1986). Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system: I. High- and low-affinity states of agonist binding to membrane bound beta adrenergic receptors. J. Pharmacol. Exp. Therapeut. 237, 154-164.
69. Contreras, M., Wolfe, B. & Molinoff, P. (1986). Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system: II. Agonist binding to soluble beta adrenergic receptors. J. Pharmacol. Exp. Therapeut. 237, 165-172.
70. Fraeyman, N., Bazan, A. & Vanscheeuwijck, P. (1994). Thermodynamic analysis of isoproterenol binding to β-adrenoceptors in rat lung membranes. Eur. J. Pharmacol. 267, 63-69.
71. Borea, P., Varani, K., Guerra, L, Gilli, P. & Gilli, G. (1992). Binding thermodynamics of A1-adenosine receptor ligands. Mol. Neuropharmacol. 2, 273-281.
72. Black, J. & Shankley, N. (1995). Inverse agonists exposed. Nature 374, 214-215.
73. Bond, R., et al., & Lefkowitz, R.J. (1995). Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta2 adrenoceptor. Nature 374, 272-276.
74. Schambye, H., Hjorth, S., Bergsma, D., Sathe, G. & Schwartz, T. (1994). Differentiation between binding sites for angiotensin II and non-peptide antagonists on the AT1 receptors. Proc. Natl Acad. Sci. USA 91, 7046-7050.
75. Ruffolo, R. (1993). Drug receptor theory. Drug News & Perspective 6, 12-23.
76. Ward, P., Ewan, G., Jordan, C., Ireland, S., Hagan, R. & Brown, J. (1990). Potent and highly selective neurokinin antagonists. J. Med. Chem. 33, 1848-1851.
77. Perlman, S., Schambye, HT., Rivero, R.A., Greenlee, W.J., Hjorth, S.A. & Schwartz, T.W. (1995). Nonpeptide angiotensin agonist - functional and molecular interaction with the at(1) receptor. J. Biol. Chem. 270, 1493-1496.
78. Kivlighn, S., et al., & Siegl, P.K.S. (1995). Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II. Am. J. Physiol. 268, R820-R823.
79. Dezube, M., et al., & Triantafillou, J.A. (1995). Modification of receptor selectivity and functional-activity in cholecystokinin peptoid ligands. J. Med. Chem. 38, 3384-3390.
80. Johansson, B., Parkinson, F. & Fredholm, B. (1992). Effects of monovalent and divalent ions on the binding of the adenosine analog CGS-21680 to adenosine-A2 receptors in rat striatum. Biochem. Pharmacol. 44, 2365-2370.
81. Ma, H. & Green, R. (1992). Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists. Mol. Pharmacol. 42, 831-837.